Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)最新文献_第9页

[Oral allergy syndrome (OAS)]. [口腔过敏综合征（OAS）]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-12-31 DOI: 10.29262/ram.v70i4.1315

María Isabel Rojo Gutiérrez, Diego Ballesteros González

引用次数: 0

[Patch test in the diagnosis of food allergy]. [食物过敏诊断中的斑贴试验]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-12-31 DOI: 10.29262/ram.v70i4.1336

Selva Iris Ale

{"title":"[Patch test in the diagnosis of food allergy].","authors":"Selva Iris Ale","doi":"10.29262/ram.v70i4.1336","DOIUrl":"https://doi.org/10.29262/ram.v70i4.1336","url":null,"abstract":"Food allergens are capable of producing adverse reactions through multiple mechanisms of an allergic or non-allergic nature, and through different routes of exposure; generally by ingestion or contact, as in protein contact dermatitis or contact urticaria, including inhalation. Food allergy reactions, in turn, can be mediated by immediate hypersensitivity mechanisms, delayed hypersensitivity or mixed immediate-delayed mechanisms. The reference diagnostic method in food allergy is the double-blind placebo-controlled food challenge test (DBPCFC), but skin and serological tests are important in the clinical context. The diagnosis of immediate food allergy depends on well-standardized allergological tests, such as the skin prick test (SPT) or specific IgE dosing, which are ideally tested by food challenge testing. However, the diagnosis of delayed mechanism food allergy and mixed allergies, which combine both immune mechanisms, is more complex. Delayed hypersensitivity reactions are evaluated with the epicutaneous patch test, or patch testing, for the diagnosis of contact dermatitis. The atopy patch test is initially used for the investigation of inflammatory reactions, which may be linked to food allergens in patients with atopic dermatitis. It was later applied in other diseases, whose pathogenesis is mainly mediated by a mechanism of delayed hypersensitivity to protein allergens: eosinophilic esophagitis, enterocolitis induced by food proteins, protein contact dermatitis, contact urticaria, among other disorders.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"250-254"},"PeriodicalIF":0.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140178621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Provocation tests]. [挑衅测试]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-12-31 DOI: 10.29262/ram.v70i4.1311

Lucila Camargo López de Oliveira, Beni Morgenstern

引用次数: 0

[Skin test (Skin Prick Test) in food allergy]. [食物过敏的皮肤测试（皮肤点刺试验）]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-12-31 DOI: 10.29262/ram.v70i4.1310

Pablo Torres Córdova

{"title":"[Skin test (Skin Prick Test) in food allergy].","authors":"Pablo Torres Córdova","doi":"10.29262/ram.v70i4.1310","DOIUrl":"https://doi.org/10.29262/ram.v70i4.1310","url":null,"abstract":"Skin tests, also known as prick tests, in food allergies are restricted to IgE-mediated food allergies, with results that barely indicate sensitization to a certain food and do not necessarily suggest food allergy. The clinical context of the patient is the decisive point before performing any type of food allergy skin test; Contextualizing and relating the patient's clinical picture with the immunological mechanism of IgE-mediated allergies will allow a better selection of the allergy test for each case. Positive tests should be interpreted more carefully, and consider that during early childhood it is common that several patients may have negative specific serum IgE tests in the blood for food allergens compared to those performed on the skin, which are positive. Skin testing can be carried out with standardized strata of foods, but they are not always available for all foods and some are very unstable. Skin tests can even be performed with raw foods, using the prick to prick technique to perform the puncture with fresh foods (especially fruits or vegetables) or other products that are not commercially available. The skin prick test is a test where, after having placed the allergenic extract in drops or with fresh food itself, the puncture must be carried out with a standardized lancet.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"242-244"},"PeriodicalIF":0.0,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140178628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Food anaphylaxis]. [食物过敏性休克]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-12-31 DOI: 10.29262/ram.v70i4.1341

María Isabel Rojo Gutiérrez, Marylin Valentín Rostan, Patricia Latour Staffeld, Edgardo José Jares

引用次数: 0

[Asociación de exposición a humo de camiones en adolescentes con asma de un centro de referencia del noreste de México]. [墨西哥东北部一个参考中心的哮喘青少年卡车烟雾暴露协会]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1290

Valeria González-González, Sandra Nora González-Díaz, Carlos Macouzet-Sánchez, Laura Abigail Martínez-Manzano, Rosa Ivett Guzmán-Avilán, Daniel Verduzco-Félix

{"title":"[Asociación de exposición a humo de camiones en adolescentes con asma de un centro de referencia del noreste de México].","authors":"Valeria González-González, Sandra Nora González-Díaz, Carlos Macouzet-Sánchez, Laura Abigail Martínez-Manzano, Rosa Ivett Guzmán-Avilán, Daniel Verduzco-Félix","doi":"10.29262/ram.v70i3.1290","DOIUrl":"10.29262/ram.v70i3.1290","url":null,"abstract":"Objective: To compare whether adolescents who are exposed to truck smoke have a higher prevalence of asthma symptomatology versus those who are not exposed.Methods: A cross-sectional, descriptive, and comparative study. Adolescents aged 13 and 14 years were included and completed a self-report questionnaire. Subjects were selected following the same methodology as in ISAAC phase III. They underwent an epidemiological survey for the presence of symptoms. Ex- posure to truck smoke was defined as passing trucks most of the day as perceived by the patient. The distribution was assessed with the Kolmogorov-Smirnov test. Comparisons with Chi-square or Student's t-test, as appropriate. A value of p³0.05 was considered statistically significant.Results: A total of 492 patients were included. The demographic variables can be seen in Table 1. When performing the association between the groups of ad- olescents with asthma exposed to truck smoke, a significant difference was found in the prevalence of respiratory symptomatology and asthma (26.0% vs 9.6%, p=0.000) (Table 1).Conclusions: Adolescent patients with asthma who are exposed to truck smoke demonstrated a significant difference in the presence of respiratory symptom- atology and asthma compared to patients without exposure.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"193"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Experiencia inicial de Lanadelumab en una paciente mexicana con angioedema hereditario tipo I]. [Lanadelumab在一名墨西哥遗传性I型血管性水肿患者中的初步经验]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1270

Carolina García-Rosas, J Jesús López-Tiro, Angélica Contreras-Contreras, Martha Ruiz-Peñaloza, Zayra Estefanía Ortiz-Monteón

{"title":"[Experiencia inicial de Lanadelumab en una paciente mexicana con angioedema hereditario tipo I].","authors":"Carolina García-Rosas, J Jesús López-Tiro, Angélica Contreras-Contreras, Martha Ruiz-Peñaloza, Zayra Estefanía Ortiz-Monteón","doi":"10.29262/ram.v70i3.1270","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1270","url":null,"abstract":"Background: Hereditary angioedema type 1 (HAE1) is an autosomal dominant disorder, characterized by quantitative and qualitative deficiency of C1 inhibitor, excessive production of bradykinin and causing recurrent angioedema in varying degrees of severity that affects quality of life and life itself. from the patients. Lanadelumab is a human monoclonal antibody, a specific inhibitor of plasma kallikrein, approved for long-term prophylaxis of HAE1.Case report: A 59-year-old female patient, diagnosed with HAE 1 since November 1987, without therapeutic response to danazol, fresh frozen plasma, or C1 inhibitor derived from intravenous plasma, requiring 3 to 9 monthly vials of icatibant acetate due to angioedema. laryngeal, cutaneous and visceral with highly altered quality of life indices. Lanadelumab 300 mg subcutaneously every 14 days was started. At the start of treatment, the AECT1 score was 1 point; AE-Qol2: 57 points, AAS3: 32 points, being followed up at 5, 10 and 12 months. After one year of treatment, the records showed an AECT1 of 19 points; AE-Qol2: 36 points and AAS3: 5 points. The requirement for icatibant acetate has been no more than 3 vials per month.Conclusion: In accordance with the literature, lanadelumab offered a significant decrease in angioedema activity and a significantly positive impact on the pa- tient's quality of life, confirming that lanadelumab is an effective option for long-term HAE prophylaxis. .","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"194"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Efectividad de la suspensión bacteriana sublingual en la prevención de infecciones de vías aéreas de repetición en pediatría]. [舌下细菌悬液在预防儿科反复呼吸道感染中的有效性]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1292

Edgar Cervantes-Trujano, Iris Estrada-García, Isabel Wong Baeza, Jessica Castañeda Casimiro, María Del Consuelo Andaluz Garza

{"title":"[Efectividad de la suspensión bacteriana sublingual en la prevención de infecciones de vías aéreas de repetición en pediatría].","authors":"Edgar Cervantes-Trujano, Iris Estrada-García, Isabel Wong Baeza, Jessica Castañeda Casimiro, María Del Consuelo Andaluz Garza","doi":"10.29262/ram.v70i3.1292","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1292","url":null,"abstract":"Background: Upper respiratory tract infections (URIs) are very common in the pediatric population. Most of these infections are mild, but due to their chronicity they affect quality of life (QoL), in addition to high costs for medical care. The use of bacterial extracts (BE) that stimulate general immunity can reduce its frequency and improve the QoL of the patient.Objective: Evaluate the effectiveness of a BE in the prevention of ARVI in children from 1 to 6 years of age.Methods: Children between the ages of 1 and 6 years, with a diagnosis of RAVI, were randomized into 3 different groups, with medical follow-up at 6 and 12 weeks after the start. The EB was administered with different doses to each group. An ANOVA test with a Tukey post hoc is used for multiple comparisons (maximum type I error of 0.05).Results: 33 children (12 girls) with a mean age of 3.11 years were included. The average frequency of RAVI prior to treatment was 2.2 events/month and 0.9 and 0.4 events/month at 6 and 12 weeks, respectively. The IVARS were reduced by 76.9% at 3 months of treatment. (Graph). No adverse effects were reported.Conclusions: BE is safe and effective in reducing the frequency of RAVI in children, in agreement with the literature. There is not enough published scientific evidence, but the BE seems to have an application in the prevention and treatment of RAVI. Sublingual administration is comfortable in this age group.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"206"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1256

Nadia Karina Aguilar Hinojosa, Evelyn Itzamara Figueroa Saavedra

引用次数: 0

[Algoritmo de tratamiento de la dermatitis atópica en Perú. Consenso de expertos]. [秘鲁特应性皮炎治疗算法。专家共识]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1228

Pablo Butron, Cesar Galvan, Rosalía Ballona, Evelyn Giuliana Castro-Vargas, Francisco Bravo-Puccio, José Enrique Gereda-Solari, José Ignacio Larco-Sousa, Edgar Matos, Rosario Torres-Ibérico

{"title":"[Algoritmo de tratamiento de la dermatitis atópica en Perú. Consenso de expertos].","authors":"Pablo Butron, Cesar Galvan, Rosalía Ballona, Evelyn Giuliana Castro-Vargas, Francisco Bravo-Puccio, José Enrique Gereda-Solari, José Ignacio Larco-Sousa, Edgar Matos, Rosario Torres-Ibérico","doi":"10.29262/ram.v70i3.1228","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1228","url":null,"abstract":"Objective: Atopic dermatitis is a chronic, systemic, relapsing disease with dermatological manifestations, which imposes a high burden on patients, families and the health care system and has a high psychological, social, and economic impact and on the quality of life of patients. It mainly affects the pediatric population and, to a lesser extent, the adult population. The clinical presentation varies according to the age and evolution of the disease, and currently there are multiple pharmacological and non-pharmacological therapies available for the symptomatic management of patients.Methods: To present an algorithm for the management of atopic dermatitis, proposed as a series of recommendations on the management, diagnosis, education, and follow-up of these patients.Results: A consensus was reached using the nominal group technique. The methodology was developed in 7 phases, including: posing the research questions, literature search, an initial proposal of recommendations, elaboration of the final recommendations and the management algorithm with three voting cycles, consensus was established with 80% favorability.Conclusions: The result of the consensus process is a management algorithm for patients with mild, moderate/severe atopic dermatitis derived from expert recommendations. The algorithm establishes diagnostic and treatment criteria and provides updated recommendations, including all therapeutic alternatives available in Peru for the management of patients with mild, moderate, and severe atopic dermatitis.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"167-186"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0